These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21038845)

  • 1. Pharmacokinetics of a losartan potassium released from a transdermal therapeutic system for the treatment of hypertension.
    Shams MS; Alam MI; Ali A; Sultana Y; Aqil M; Shakeel F
    Pharmazie; 2010 Sep; 65(9):679-82. PubMed ID: 21038845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics of a losartan transdermal system for the treatment of hypertension.
    Shams MS; Alam MI; Ali A; Sultana Y; Aqil M
    Drug Dev Ind Pharm; 2010 Apr; 36(4):385-92. PubMed ID: 20205600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proniosomal transdermal therapeutic system of losartan potassium: development and pharmacokinetic evaluation.
    Thakur R; Anwer MK; Shams MS; Ali A; Khar RK; Shakeel F; Taha EI
    J Drug Target; 2009 Jul; 17(6):442-9. PubMed ID: 19527115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and in vivo evaluation of an indapamide transdermal patch.
    Ren C; Fang L; Ling L; Wang Q; Liu S; Zhao L; He Z
    Int J Pharm; 2009 Mar; 370(1-2):129-35. PubMed ID: 19114099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal therapeutic system of isradipine: effect of hydrophilic and hydrophobic matrix on in vitro and ex vivo characteristics.
    Tirunagari M; Jangala VR; Khagga M; Gannu R
    Arch Pharm Res; 2010 Jul; 33(7):1025-33. PubMed ID: 20661712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel transdermal patch incorporating isosorbide dinitrate with bisoprolol: in vitro and in vivo characterization.
    Zhao JH; Fu JH; Wang SM; Su CH; Shan Y; Kong SJ; Wang Y; Lu WL; Zhang H; Zhang S; Li L; Zhang EH; Wang L; Pei QL; Wang JC; Zhang X; Zhang Q
    Int J Pharm; 2007 Jun; 337(1-2):88-101. PubMed ID: 17267147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A drug-in-adhesive transdermal patch for S-amlodipine free base: in vitro and in vivo characterization.
    Sun Y; Fang L; Zhu M; Li W; Meng P; Li L; He Z
    Int J Pharm; 2009 Dec; 382(1-2):165-71. PubMed ID: 19716871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and evaluation of patches for transdermal delivery of losartan potassium.
    Baviskar DT; Parik VB; Gupta HN; Maniyar AH; Jain DK
    PDA J Pharm Sci Technol; 2012; 66(2):126-35. PubMed ID: 22492598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of carvedilol-loaded transdermal drug delivery system: In-vitro and in-vivo characterization study.
    Kshirsagar SJ; Bhalekar MR; Mohapatra SK
    Drug Dev Ind Pharm; 2012 Dec; 38(12):1530-7. PubMed ID: 22356303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics of two tablet formulations of Losartan: bioequivalence assessment.
    Tamimi JJ; Salem II; Mahmood Alam S; Zaman Q; Dham R
    Biopharm Drug Dispos; 2005 Jul; 26(5):205-10. PubMed ID: 15906418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal therapeutic system of enalapril maleate using piperidine as penetration enhancer.
    Aqil M; Bhavna ; Chowdhary I; Sultana Y; Talegaonkar S; Ahmad FJ; Ali MM
    Curr Drug Deliv; 2008 Apr; 5(2):148-52. PubMed ID: 18393818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Losartan Potassium and Verapamil Hydrochloride Compound Transdermal Drug Delivery System: Formulation and Characterization.
    Chen YS; Sun YY; Qin ZC; Zhang SY; Chen WB; Liu YQ
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Damar Batu as a novel matrix former for the transdermal drug delivery: in vitro evaluation.
    Mundada AS; Avari JG
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1147-54. PubMed ID: 19555240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of a once-daily extended-release formulation of pramipexole in healthy male volunteers: three studies.
    Jenner P; Könen-Bergmann M; Schepers C; Haertter S
    Clin Ther; 2009 Nov; 31(11):2698-711. PubMed ID: 20110012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo assessment of matrix type transdermal therapeutic system of labetalol hydrochloride.
    Mittal A; Parmar S; Singh B
    Curr Drug Deliv; 2009 Oct; 6(5):511-9. PubMed ID: 19863491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, safety, and antihypertensive efficacy of losartan in combination with hydrochlorothiazide in hypertensive patients with renal impairment.
    Dickson TZ; Zagrobelny J; Lin CC; Ritter MA; Snavely D; Ramjit D; Shahinfar S; Lo MW
    J Clin Pharmacol; 2003 Jun; 43(6):591-603. PubMed ID: 12817522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of component of microemulsion for transdermal delivery of nicardipine hydrochloride.
    Wu PC; Lin YH; Chang JS; Huang YB; Tsai YH
    Drug Dev Ind Pharm; 2010 Dec; 36(12):1398-403. PubMed ID: 20545507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies.
    Panchagnula R; Bokalial R; Sharma P; Khandavilli S
    Int J Pharm; 2005 Apr; 293(1-2):213-23. PubMed ID: 15778059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical pharmacology of losartan in Japanese subjects and patients.
    Nakashima M; Umemura K
    Blood Press Suppl; 1996; 2():62-6. PubMed ID: 8913542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of metoprolol tartrate containing matrix type transdermal drug delivery system.
    Malipeddi VR; Awasthi R; Ghisleni DD; de Souza Braga M; Kikuchi IS; de Jesus Andreoli Pinto T; Dua K
    Drug Deliv Transl Res; 2017 Feb; 7(1):66-76. PubMed ID: 27677866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.